Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

LACOSAMIDA INTAS 100 MG COMPRIMIDOS EFERVESCENTES EFG - CIMA-AEMPS Drug Approval Details

Approvals/CIMA-AEMPS/LACOSAMIDA INTAS 100 MG COMPRIMIDOS EFERVESCENTES EFG

Approved

STANDARD

LACOSAMIDA INTAS 100 MG COMPRIMIDOS EFERVESCENTES EFG

Intas Third Party Sales 2005 S.L.🇪🇸 Spanish Agency of Medicines and Medical Devices

Approval Date: Feb 13, 2024
Approval ID: 5523e7384aec2f03
Company: Intas Third Party Sales 2005 S.L.
Type: Standard

Approval Details

Approval Id: 5523e7384aec2f03
Drug Cima Aemps Name: LACOSAMIDA INTAS 100 MG COMPRIMIDOS EFERVESCENTES EFG
Register Number: 89337
Holder Company Name: Intas Third Party Sales 2005 S.L.
Marketing Company Name: Intas Third Party Sales 2005 S.L.
Authorization Date: 2024-02-13
Dosage Form: COMPRIMIDO EFERVESCENTE
Dose: 100 mg
Route Of Administration: VÍA ORAL
Prescription Type: Medicamento Sujeto A Prescripción Médica
Commercialized: No
Company Name: Intas Third Party Sales 2005 S.L.

Active Ingredients

LACOSAMIDA

100 mg

Approved

Quick Info

Agency

CIMA-AEMPS

Country

🇪🇸

Approval Date

Feb 13, 2024

Approval ID

5523e7384aec2f03

Type

Standard

Back to CIMA-AEMPS Approvals